glp-1 fda approved for pcos What's next for GLP-1 innovation: A primer on the race reshaping pharma and chronic disease care

Doctors report that GLP-1 medications, originally approved for obesity and diabetes, are increasingly being used to help women with Polycystic Ovary Syndrome (PCOS) — a hormonal disorder often tied to weight gain,

27.61

★★★★☆4.8 (126)

For some women with infertility, GLP-1s may hold an unexpected benefit: Pregnancy

29.54

★★★★★4.9 (98)

Today, we approved the first generic for an injectable GLP-1 used to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes as an adjunct

26.80

★★★★★5.0 (157)

Rising use of GLP-1 medications among women with PCOS

25.27

★★★★★4.7 (84)

The 5 peptides in this carousel represent different points on the evidence spectrum: ✦ Some are FDA approved with landmark clinical trial data ✦ Some are approved for specific indications with growing

29.37

★★★★★4.9 (203)

GLP-1 Genetics: How Genes Affect Appetite, Semaglutide, and Tirzepatide Response

25.31

★★★★★5.0 (176)

Women with PCOS seek relief in weight-loss drugs

20.19

★★★★★4.8 (132)